Baxter International Inc. stock is up 3.83% since 30 days ago. The next earnings date is Feb 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 62% of the previous 49 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 8 CALLs, 2 PUTs. 0% of analysts rate it a buy.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
29 Nov 19:36 | 01 Dec, 2023 | 34.00 | 3004 | ||
29 Nov 19:36 | 01 Dec, 2023 | 34.00 | 3004 | ||
29 Nov 19:36 | 01 Dec, 2023 | 34.00 | 3004 | ||
29 Nov 19:59 | 01 Dec, 2023 | 34.00 | 3004 | ||
29 Nov 20:00 | 01 Dec, 2023 | 34.00 | 3004 | ||
29 Nov 20:00 | 01 Dec, 2023 | 34.00 | 3004 | ||
04 Dec 16:25 | 16 Feb, 2024 | 42.50 | 312 | ||
05 Dec 14:43 | 17 Jan, 2025 | 32.50 | 415 | ||
05 Dec 15:25 | 21 Jun, 2024 | 37.50 | 5 | ||
05 Dec 17:33 | 16 Feb, 2024 | 42.50 | 312 |
Baxter International Inc. develops and provides a portfolio of healthcare products worldwide. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries.